Skip to content
value.today

Immuron Ltd vs Moderna, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Moderna, Inc. is the larger company by market value: $90.1 B against $9 M for Immuron Ltd, 10015 times as much (market caps of Aug 1, 2026 for Immuron Ltd and Oct 30, 2026 for Moderna, Inc.). Immuron Ltd's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
  • Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $5 M for Immuron Ltd in the year to June 2025.
  • Both made a net loss: $3 M for Immuron Ltd and $2.8 B for Moderna, Inc.
  • Immuron Ltd keeps more of each dollar of sales: a net margin of -71.6% against -145.2% for Moderna, Inc.
  • Immuron Ltd's revenue grew faster in its latest fiscal year: +47.0% against -39.9% for Moderna, Inc.
  • Their Altman Z-scores put Immuron Ltd in the distress zone and Moderna, Inc. in the safe zone.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0342685102713702020202120222023202420252026Immuron Ltd 56Moderna, Inc. 1370

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$5B$10B$14B$19B201720182019202020212022202320242025Immuron Ltd $0BModerna, Inc. $2B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureImmuron Ltd
IMRN · #26,008 in the world
Moderna, Inc.
MRNA · #274 in the world
Profile
Country🇦🇺 Australia🇺🇸 USA
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded—2010
Size
Market cap$9 M$90.1 B
Revenue$5 M$1.9 B
Net income$-3 M▲ best$-2.8 B
Employees—4,700
Valuation
Price to sales1.9×35.7×
Price to book1.7×10.4×
Free cash flow yield-42.8%-2.3%▲ best
Profitability
Gross margin65.5%▲ best55.4%
Operating margin-73.3%▲ best-158.1%
Net margin-71.6%▲ best-145.2%
Return on equity-49.2%-28.9%▲ best
Growth
Revenue growth47.0%▲ best-39.9%
Revenue growth, 3 years a year103.5%▲ best-53.4%
Financial strength
Debt to equity—0.1×
Cash
Free cash flow margin—-106.2%
Shareholder returns
Shareholder yield—0.0%
Strength scores
Piotroski F-score—3 of 9
Altman Z-score zonedistresssafe
Data as ofMarket cap Aug 2026; ratios FY2025Market cap Oct 2026; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, Immuron Ltd or Moderna, Inc.?

Moderna, Inc. is the larger company by market value: $90.1 B against $9 M for Immuron Ltd, 10015 times as much (market caps of Aug 1, 2026 for Immuron Ltd and Oct 30, 2026 for Moderna, Inc.). Immuron Ltd's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.

Which makes more money, Immuron Ltd or Moderna, Inc.?

Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $5 M for Immuron Ltd in the year to June 2025. Both made a net loss: $3 M for Immuron Ltd and $2.8 B for Moderna, Inc.

Which is more profitable, Immuron Ltd or Moderna, Inc.?

Immuron Ltd keeps more of each dollar of sales: a net margin of -71.6% against -145.2% for Moderna, Inc.

Which is growing faster, Immuron Ltd or Moderna, Inc.?

Immuron Ltd's revenue grew faster in its latest fiscal year: +47.0% against -39.9% for Moderna, Inc.

Which is financially stronger, Immuron Ltd or Moderna, Inc.?

Their Altman Z-scores put Immuron Ltd in the distress zone and Moderna, Inc. in the safe zone.

Sources#

Every figure on this page comes from these, with the date shown next to it.